Clinical Trials Logo

Filter by:
NCT ID: NCT00074581 Completed - HIV Infections Clinical Trials

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Start date: February 2005
Phase: Phase 3
Study type: Interventional

This study will determine whether anti-HIV drugs can prevent the sexual transmission of HIV among couples in which one partner is HIV infected and the other is not.

NCT ID: NCT00074425 Completed - HIV Infections Clinical Trials

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

Start date: January 2005
Phase: Phase 2
Study type: Interventional

The majority of HIV infected people worldwide became infected with the virus through heterosexual contact. BufferGel and PRO 2000 Gel are vaginal gels designed to prevent women from becoming infected with HIV during sexual intercourse with an HIV infected partner. This study will test the safety and effectiveness of these gels.

NCT ID: NCT00074412 Completed - HIV Infections Clinical Trials

Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding

Start date: January 2007
Phase: Phase 3
Study type: Interventional

The many benefits of breastfeeding are well documented. However, because of the risk of mother-to-child transmission (MTCT) of HIV from an HIV infected mother to her infant, there is considerable concern over the practice, especially in developing countries. The purpose of this study is to determine the safety and effectiveness of the anti-HIV drug nevirapine (NVP) in preventing MTCT of HIV in breastfeeding infants born to HIV infected women in South Africa, Tanzania, Uganda, and Zimbabwe.